People Background Check
Find People:

David Joel Pinsky, Age 643600 Daleview Dr, Ann Arbor, MI 48105

Get Report
Known as:
David J Pinsky Dave J Pinsky David Binsky
Related to:
Janice P Sanchez 68

David Pinsky Phones & Addresses

3600 Daleview Dr, Ann Arbor, MI 48105

3610 Daleview Dr, Ann Arbor, MI 48105

33 Barton North Dr, Ann Arbor, MI 48105 (734) 222-8280

23 Kennedy Dr, Cresskill, NJ 07626 (201) 567-7591

3935 Blackstone Ave, Bronx, NY 10471 (718) 601-3124

Nokesville, VA

New York, NY

Show more

Work

Company: REGENTS OF THE UNIVERSITY OF MICHIGAN Address: 1500 E Medical Center Dr Suite 3914, Ann Arbor, MI 48109 Phones: (734) 936-5548 (Phone) (734) 936-9621 (Fax)

Education

School / High School: Ohio State University / College of Medicine 1985

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Cardiovascular Disease, 2002

Mentions for David Joel Pinsky

Career records & work history

Lawyers & Attorneys

David Pinsky Photo 1

David Zorian Pinsky, New York NY - Lawyer

Address:
Covington & Burling LLP
620 8Th Ave, New York, NY 10018
(212) 841-1177 (Office)
Licenses:
New York - Currently registered 2006
Education:
New York University School of LawDegree JD - Juris Doctor
Specialties:
Fraud - 34%
Immigration - 33%
Litigation - 33%

Medicine Doctors

David Pinsky Photo 2

Dr. David J Pinsky, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
1500 E Medical Center Dr Suite 3, Ann Arbor, MI 48109
(734) 647-7321 (Phone) (734) 936-7392 (Fax)
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Center Dr Suite 3914, Ann Arbor, MI 48109
(734) 936-5548 (Phone) (734) 936-9621 (Fax)
Procedures:
Ablation for Treatment of Cardiac Arrythmias
Cardiac Catheterization (incl. Coronary Angiography)
Cardiac Myocardial Perfusion Imaging
Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
Coronary Angioplasty, Atherectomy and Stent
Impella Device
Peripheral Artery Catheterization
Thoracentesis
Conditions:
Angina and Acute Coronary Syndrome
Aortic Valve Disease
Arrhythmias (incl. Atrial Fibrillation)
Cardiomyopathy
Congenital Heart Disease
Congestive Heart Failure
Coronary Artery Disease (CAD)
Heart Attack (Acute Myocardial Infarction)
Hyperlipidemia
Hypertension
Hypertensive Heart and Chronic Kidney Disease
Hypotension
Mitral Valve Disease
Pulmonary Hypertension
Septal Defect
Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 2002
Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr Suite 3, Ann Arbor, MI 48109
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Center Dr Suite 3914, Ann Arbor, MI 48109
University of Michigan Health System
1500 East Medical Center Drive Spc 5474, Ann Arbor, MI 48109
Education:
Medical School
Ohio State University / College of Medicine
Graduated: 1985
Medical School
Mount Sinai Hospital
Graduated: 1985

David J. Pinsky

Specialties:
Cardiovascular Disease
Work:
University Michigan Cardiovascular Center
1500 E Medical Ctr Dr FL 3, Ann Arbor, MI 48109
(888) 287-1082 (phone) (734) 232-2051 (fax)
Education:
Medical School
Ohio State University College of Medicine
Graduated: 1985
Procedures:
Cardioversion
Conditions:
Acute Myocardial Infarction (AMI), Acute Renal Failure, Angina Pectoris, Diabetes Mellitus (DM), Endocarditis, Heart Failure, Hypertension (HTN), Ischemic Heart Disease, Mitral Valvular Disease
Languages:
English, Spanish
Description:
Dr. Pinsky graduated from the Ohio State University College of Medicine in 1985. He works in Ann Arbor, MI and specializes in Cardiovascular Disease. Dr. Pinsky is affiliated with University Of Michigan Hospitals & Health Center.

David D. Pinsky

Specialties:
Internal Medicine
Work:
David D Pinsky MD
2050 Huntington Dr STE D, South Pasadena, CA 91030
(626) 799-4151 (phone) (626) 799-4207 (fax)
Education:
Medical School
University of Southern California Keck School of Medicine
Graduated: 1984
Conditions:
Alopecia Areata, Atrial Fibrillation and Atrial Flutter, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Gout, Hypertension (HTN), Hypothyroidism
Languages:
English
Description:
Dr. Pinsky graduated from the University of Southern California Keck School of Medicine in 1984. He works in South Pasadena, CA and specializes in Internal Medicine. Dr. Pinsky is affiliated with Huntington Memorial Hospital.
David Pinsky Photo 3

David Drew Pinsky

Specialties:
Internal Medicine
Addiction Medicine
Education:
University of Southern California(1984)
Huntington Memorial Hospital *Internal Medicine
David Pinsky Photo 4

David J Pinsky, Ann Arbor MI

Specialties:
Cardiologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Ohio State University, College of Medicine - Doctor of Medicine
Mount Sinai Hospital, The - Fellowship - Cardiology
Mount Sinai Hospital, The - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine

David Pinsky resumes & CV records

Resumes

David Pinsky Photo 35

David Pinsky

David Pinsky Photo 36

David Pinsky

David Pinsky Photo 37

Student At University Of Florida

Position:
Intern at TradeStation Securities
Location:
Gainesville, Florida
Industry:
Financial Services
Work:
TradeStation Securities since May 2013
Intern RMP Financial Inc. May 2012 - Aug 2012
Analyst Intern
Education:
University of Florida 2012 - 2016
Bachelor of Science (BS), Finance
Interests:
Traveling, Investing, Startups, Tennis

Publications & IP owners

Us Patents

Cd39/Ecto-Adpase As A Treatment For Thrombotic And Ischemic Disorders

US Patent:
6867177, Mar 15, 2005
Filed:
Aug 13, 1999
Appl. No.:
09/374586
Inventors:
David J. Pinsky - Cresskill NJ, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A01N037/18
C07K001/00
US Classification:
514 2, 530350
Abstract:
The present invention provides a method of treating or preventing thrombotic or ischemic disorders in a subject which comprises administering an agent to the subject, wherein the agent inhibits ADP-mediated platelet aggregation by increasing ADP catabolism, and a method for determining whether a compound inhibits platelet aggregation by increasing ADP catabolism so as to treat or prevent thrombotic or ischemic disorders in a subject, comprising: (a) inducing thrombotic or ischemic disorders in an animal, which animal is an animal model for thrombotic or ischemic disorders; (b) measuring the stroke outcome in the animal, (c) measuring platelet deposition and/or fibrin deposition in ischemic tissue, and (d) comparing the stroke outcome in step (b) and the platelet deposition and/or fibrin deposition with that of the animal model in the absence of the compound so as to identify a compound capable of treating or preventing thrombotic or ischemic disorders in a subject.

Methods For Suppressing Early Growth Response—1Protein (Egr-1) To Reduce Vascular Injury In A Subject

US Patent:
6969704, Nov 29, 2005
Filed:
Aug 25, 2000
Appl. No.:
09/648389
Inventors:
David Pinsky - Cresskill NJ, US
David M. Stern - Great Neck NY, US
Shi-Fang Yan - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K031/07
A01N043/04
C07H021/04
C12Q001/68
US Classification:
514 44, 536 231, 536 243, 536 2433, 536 245
Abstract:
The invention provides a method for reducing damage to an ischemic tissue which comprises contacting cells of the tissue with an inhibitor of Early Growth Response Factor-1 Protein (Egr-1). In addition, the invention provides a method for reducing vascular injury during reperfusion of an ischemic tissue in a subject which comprises contacting the tissue with a compound which inhibits expression of Early Growth Response Factor-1 (Egr-1) protein in the tissue so as to reduce vascular injury in the tissue during reperfusion. wherein the inhibitor is a nucleic acid consisting essentially of the polynucleotide sequence 5′-CTTGGCCGCTGCCAT-3′ (SEQ ID NO:1). In one embodiment of the invention, the subject has suffered a stroke, or a myocardial infarction. In another embodiment of the invention, the subject is undergoing or has undergone angioplasty, cardiac surgery, vascular surgery, or organ transplantation.

Methods For Treating Ischemic Disorders Using Carbon Monoxide

US Patent:
8128963, Mar 6, 2012
Filed:
Oct 3, 2003
Appl. No.:
10/679135
Inventors:
David J. Pinsky - Ann Arbor MI, US
David M. Stern - Augusta GA, US
Assignee:
The Trustees of Columbia University in the City Of New York - New York NY
International Classification:
A61K 33/00
A61P 9/10
US Classification:
424699, 435 11
Abstract:
The present invention provides for a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of a selectin antagonist in a sufficient amount over a sufficient time period to prevent white blood cell accumulation so as to treat the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject carbon monoxide gas in a sufficient amount over a sufficient period of time thereby treating the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IX in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject.

Methods For Treating An Ischemic Disorder And Improving Stroke Outcome

US Patent:
2005025, Nov 10, 2005
Filed:
Oct 22, 2003
Appl. No.:
10/692439
Inventors:
David Pinsky - Cresskill NJ, US
David Stern - Great Neck NY, US
Ann Schmidt - Franklin Lakes NJ, US
Eric Rose - Tenafly NJ, US
Robert Solomon - Palisades NY, US
International Classification:
A61K048/00
A61K039/395
A61K038/37
US Classification:
514012000, 424145100, 514044000
Abstract:
The present invention provides for a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable Factor IXa compound in a sufficient amount over a sufficient time period so as to treat the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IXa in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject.

Cd39/Ecto-Adpase For Treatment Of Thrombotic And Ischemic Disorders

US Patent:
2006000, Jan 5, 2006
Filed:
Mar 30, 2005
Appl. No.:
11/093814
Inventors:
David Pinsky - Cresskill NJ, US
Assignee:
The Trustees of Columbia University - New York NY
International Classification:
A61K 38/17
US Classification:
514012000
Abstract:
The present invention relates to a method for treating an ischemic disorder in a subject which comprises administering to the subject a CD39 polypeptide (SEQ ID NO:2) or an active fragment thereof which inhibits ADP or ATP mediated platelet aggregation or leukocyte accumulation so as to treat the ischemic disorder in the subject.

Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Analogues Of Camp And Cgmp

US Patent:
2006013, Jun 22, 2006
Filed:
Jul 1, 2005
Appl. No.:
11/173537
Inventors:
Yoshifumi Naka - Cliffside Park NJ, US
David Pinsky - Ann Arbor MI, US
David Stern - Augusta GA, US
International Classification:
C12N 5/08
A61K 35/14
A61K 31/7076
A61K 31/52
US Classification:
424093700, 435366000, 514046000, 514263240
Abstract:
The present invention relates to ex vivo methods for preserving/maintaining blood vessels that are to be used as vascular grafts. The present invention also relates to compositions comprising an analogue of cAMP and/or an analogue of cGMP for use in the methods of the invention, which compositions are free of: (i) an inhibitor of Type I phosphodiesterase, (ii) an inhibitor of Type II phosphodiesterase, (iii) an inhibitor of Type III phosphodiesterase, (iv) an inhibitor of Type IV phosphodiesterase, and (v) an inhibitor of TNF-α.

Tissue Inhibitor Of Metalloproteinase (Timp) As A Marker And Predictor Of Cardiovascular Disease And Both Cardiac And Non-Cardiac Mortality

US Patent:
2006016, Jul 20, 2006
Filed:
Dec 1, 2005
Appl. No.:
11/292031
Inventors:
Erdal Cavusoglu - Douglaston NY, US
Jonathan Marmur - New York NY, US
David Pinsky - Ann Arbor MI, US
Cyril Ruwende - Ann Arbor MI, US
International Classification:
C12Q 1/68
G01N 33/53
G01N 33/00
US Classification:
435006000, 435007100, 436086000
Abstract:
The present invention is directed to a method for characterizing an individual's risk profile of developing vascular disease, for an adverse outcome in a patient, for mortality in an individual diagnosed with vascular disease by evaluating the level of tissue inhibitor of metalloproteinase-1 (TIMP-1) in a sample taken from the individual. The invention is also directed to a kit for characterizing the same.

Method For Enhancing Bone Formation

US Patent:
2006029, Dec 28, 2006
Filed:
Jul 29, 2005
Appl. No.:
11/193198
Inventors:
Regina Landesberg - Stamford CT, US
David Pinsky - Ann Arbor MI, US
Ronald Katz - Fayetteville NY, US
International Classification:
A61K 38/39
A61K 38/18
US Classification:
514012000
Abstract:
This invention provides a method for facilitating bone formation in a subject comprising delivering to a bone formation-requiring site a composition of matter comprising platelet-rich plasma, calcium, a PAR-activating agent and a bone forming material. This invention further provides a method for facilitating bone formation in a subject comprising (a) delivering to a bone formation-requiring site in the subject a composition of matter comprising platelet-rich plasma, calcium and a bone-forming material, and (b) contacting the composition so delivered with a PAR-activating agent other than thrombin. This invention further provides a method for facilitating clot formation in platelet-rich plasma with a PAR-activating agent other than thrombin. This invention further provides a method of producing a formable gel comprising the step of admixing platelet-rich plasma, calcium, a bone-forming material and a PAR-activating agent other than thrombin. Finally, this invention provides related compositions of matter and articles of manufacture.

Possible Relatives

James L Pinsky  Linda A Pinsky  Marc J Pinsky  Mark Pinsky  Michael Pinsky  Stephen H Pinsky  David J Last  David K Stancil  David J Stancombe  David R Standefer 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.